Log in

NASDAQ:OPNTOpiant Pharmaceuticals Earnings Date, Estimates & History

-0.06 (-0.65 %)
(As of 07/31/2020 04:00 PM ET)
Today's Range
Now: $9.18
50-Day Range
MA: $9.15
52-Week Range
Now: $9.18
Volume23,965 shs
Average Volume32,228 shs
Market Capitalization$39.11 million
P/E Ratio4.41
Dividend YieldN/A


Opiant Pharmaceuticals (NASDAQ:OPNT) Earnings Information

Opiant Pharmaceuticals last issued its quarterly earnings data on May 12th, 2020. The technology company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.21. The company had revenue of $4.28 million for the quarter, compared to analysts' expectations of $4.63 million. Opiant Pharmaceuticals has generated $0.20 earnings per share over the last year and currently has a price-to-earnings ratio of 4.4. Opiant Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, August 6th, 2020. Opiant Pharmaceuticals will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Opiant Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Opiant Pharmaceuticals (NASDAQ:OPNT) Earnings Estimates

2020 EPS Consensus Estimate: $0.63
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.23)($0.23)($0.23)
Q2 20201$0.13$0.13$0.13
Q3 20201$0.26$0.26$0.26
Q4 20201$0.47$0.47$0.47

Opiant Pharmaceuticals (NASDAQ OPNT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
 ($0.31)    Register (After Market Closes)
5/12/2020Q1($0.19)($0.40)($0.40)$4.63 million$4.28 millionTranscript
3/4/202012/31/2019$0.31$0.20$0.20$7.70 million$7.67 millionTranscript
11/12/20199/30/2019$0.10$1.97($1.97)$5.73 million$20.64 millionTranscript
8/8/2019Q2 2019($0.55)$0.31$0.31$3.91 million$6.78 millionN/A
5/9/20193/31/2019($0.88)($0.44)($0.44)$1.90 million$5.44 millionTranscript
3/21/20197/31/2018($0.08)($0.37)($0.37)$5.20 million$4.76 millionTranscript
11/7/2018Q3($0.11)($0.32)($0.32)$4.70 million$4.37 millionN/A
8/9/2018Q2 2018($1.07)($0.52)($0.52)$2.10 million$3.15 millionN/A
5/8/2018Q1 2018($0.29)($3.68)($3.68)$2.00 million$1.70 millionN/A
12/4/2017Q1 2018($1.19)($2.77)($2.77)$0.02 millionN/A
10/13/2017Q4 2017($0.87)($0.17)($0.17)$3.77 millionN/A
6/14/2017Q3 2017($0.82)($1.55)($1.55)$0.02 millionN/A
3/16/2017Q2 2017($0.85)$4.91$4.91$13.54 millionN/A
12/16/2016Q1 2017($1.14)($0.30)($0.30)$0.70 million$1.12 millionN/A
10/31/2016Q4 2016($0.52)($0.52)$0.10 million$0.31 millionN/A
6/8/2016Q3 2016$0.15$0.15$2.61 millionN/A
3/15/2016Q2 2016$1.52$1.52$6.86 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.